RAMÓN
GARCÍA GÓMEZ
Ikertzailea 2016-(e)ra arte
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2018
-
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain
BMC Cancer, Vol. 18, Núm. 1
-
Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267
-
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
The Lancet Oncology, Vol. 19, Núm. 4, pp. 521-536